REQUEST FOR PROPOSAL for the provision of advice and support to GARDP Foundation in the definition of the evolution of its operational model in the coming five years.
Closing date: 03.03.2025
ABOUT GARDP FOUNDATION
The Global Antibiotic Research & Development Partnership (GARDP Foundation) is a not-for-profit global health organization seated in Geneva, Switzerland. GARDP Foundation’s mission is to accelerate the development of, and access to, treatments for drug-resistant bacterial infections. It does so by forging public-private partnerships all over the world to develop and expand access to treatments for serious bacterial infections and sepsis in adults, children and newborns, as well as sexually transmitted infections (STIs).
GARDP Foundation responds to the crisis in antimicrobial resistance. In 2015, the World Health Assembly, the decision-making body of the World Health Organization (WHO), adopted the Global Action Plan on Antimicrobial Resistance. The following year, to deliver on this plan, WHO and the Drugs for Neglected Diseases initiative created GARDP Foundation. In 2018, it was legally established as an independent entity.
Since then, GARDP Foundation has developed a portfolio of antibiotic treatments targeting WHO priority pathogens, priority diseases and key populations/regions that are especially affected by antibiotic resistance. It is also pioneering new access initiatives with innovator, manufacturing and distribution partners.
As of 2025, GARDP Foundation’s team consists of about 100 people who collectively share extensive cross-sector R&D, access, business development and other relevant experience. They work with the key public and private sector stakeholders and partners, such as the research and development community, donors, industry and implementing countries.
If you are interested to receive the complete documentation, please review, complete and sign that attached confidential framework and send it to: RFP_Procurement@gardp.org.
Due/closing date: March 3rd 2025